Bristol Myers Squibb have extended their research collaboration aimed at designing and optimizing small-molecule drugs for ...

Diabetes was tied to a 3.3 times greater risk of earlier loss of walking ability in a study of amyotrophic lateral sclerosis ...

It took time for Philip to discover acceptance was key to him for living with ALS. Learn about his journey from diagnosis to ...

EKZ-102, an experimental oral therapy for amyotrophic lateral sclerosis (ALS), is on track to enter early clinical testing in ...

Although the exact causes of ALS remain unknown, both genetic and environmental factors may contribute to its development.

An AI model used seven common clinical measures of inflammation, nutritional status, and more to predict ALS prognosis, a ...

As her husband, Todd, celebrates his 55th birthday, columnist Kristin Neva reflects on what's changed since his diagnosis 15 years ago.

A Phase 3 clinical trial testing pridopidine in people with ALS is expected to start enrolling patients in January.

Advocates in Canada are urging their federal government to invest more in ALS research and trial opportunities.

Building an online store has given columnist Kristin Neva and her husband, Todd, a project to work on together.